On Monday, CorMedix Inc (NASDAQ: CRMD) was -7.43% drop from the session before settling in for the closing price of $10.36. A 52-week range for CRMD has been $3.03 – $13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -50.37% over the last five years. When this article was written, the company’s average yearly earnings per share was at 54.95%. With a float of $59.25 million, this company’s outstanding shares have now reached $60.68 million.
The firm has a total of 82 workers. Let’s measure their productivity. In terms of profitability, gross margin is 83.54%, operating margin of -405.54%, and the pretax margin is -378.34%.
CorMedix Inc (CRMD) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CorMedix Inc stocks. The insider ownership of CorMedix Inc is 2.35%, while institutional ownership is 37.80%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 54.95% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
You can see what CorMedix Inc (CRMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Analysing the last 5-days average volume posted by the [CorMedix Inc, CRMD], we can find that recorded value of 0.83 million was lower than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 24.10%. Additionally, its Average True Range was 0.60.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 29.70%, which indicates a significant increase from 0.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.79% in the past 14 days, which was lower than the 81.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.26, while its 200-day Moving Average is $7.86. Now, the first resistance to watch is $10.20. This is followed by the second major resistance level at $10.81. The third major resistance level sits at $11.12. If the price goes on to break the first support level at $9.28, it is likely to go to the next support level at $8.97. Now, if the price goes above the second support level, the third support stands at $8.36.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are 60,677K outstanding shares of the company, which has a market capitalization of 581.90 million. As of now, sales total 0 K while income totals -46,340 K. Its latest quarter income was 11,460 K while its last quarter net income were -2,780 K.
